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Abstract: Cell-penetrating peptides might have great potential for enhancing the therapeutic
effect of drug molecules against such dangerous pathogens as Mycobacterium tuberculosis (Mtb),
which causes a major health problem worldwide. A set of cationic cell-penetration peptides with
various hydrophobicity were selected and synthesized as drug carrier of isoniazid (INH), a first-line
antibacterial agent against tuberculosis. Molecular interactions between the peptides and their
INH-conjugates with cell-membrane-forming lipid layers composed of DPPC and mycolic acid
(a characteristic component of Mtb cell wall) were evaluated, using the Langmuir balance technique.
Secondary structure of the INH conjugates was analyzed and compared to that of the native
peptides by circular dichroism spectroscopic experiments performed in aqueous and membrane
mimetic environment. A correlation was found between the conjugation induced conformational
and membrane affinity changes of the INH–peptide conjugates. The degree and mode of interaction
were also characterized by AFM imaging of penetrated lipid layers. In vitro biological evaluation
was performed with Penetratin and Transportan conjugates. Results showed similar internalization
rate into EBC-1 human squamous cell carcinoma, but markedly different subcellular localization and
activity on intracellular Mtb.
Keywords: membrane affinity; cell-penetrating peptides; circular dichroism spectroscopy; atomic
force microscopy; mycolic acid; Langmuir monolayer; drug–peptide conjugates
1. Introduction
In the genus Mycobacterium, there are three dangerous pathogens for humans: Mycobacterium
tuberculosis (Mtb), M. leprae and M. lepromatosis [1]. These pathogens are causative agents of human
diseases such as tuberculosis and leprosy. Tuberculosis is still a major public health problem worldwide;
it is one of the top 10 causes of death and the leading cause from a single infectious agent (above
HIV/AIDS). In 2017, Tuberculosis caused an estimated 1.3 million deaths among HIV-negative people,
and there were an additional 300,000 deaths among HIV-positive people [2].
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During the therapeutic treatment of infectious diseases, it is important to consider the structural
and physicochemical properties of the cell envelope of mycobacteria, in order to allow the access of
drug compounds to the cell, for effective targeted drug delivery and treatments. Processes located at
the cell envelope of mycobacteria include the protection of the bacterial cell from the environment,
transport of solutes and proteins, adhesion to receptors and mechanical resistance [3]. Mycobacterium
is considered Gram-positive bacterium which possesses a lipid-rich cell envelope [4] composed
of a typical plasma membrane and a three-part complex: mycomembrane, arabinogalactan and
peptidoglycan. The mycomembrane is a specific barrier composed of mycolic acids, which are the
major chemical components (almost 40%) in the cell envelope [5–7]. Mycolic acids are exceptionally long
chain α-alkyl-β-hydroxyl fatty acids that have different conformational behavior covalently linked to
polysaccharide arabinogalactans in the cell wall [3,4,8,9]. The folding and unfolding of mycolic acids can
influence its biological function and permeability properties for drugs [7,10]. The Langmuir monolayer
is an ideal model to investigate the importance of the lateral organization and the specific functions
of lipids, use them for cell mimicking, and allows the systematic study of biomolecule–membrane
interactions. [11–13]. Hasegawa et al. studied the conformational changes of α-mycolic acid at different
surface pressures by using Langmuir–Blodgett technique and atomic force microscopy (AFM) [14].
It was found that α-mycolic acid formed a stable Langmuir monolayer and it is entirely expanded
when the surface pressure is high. In experimental model systems, mammalian membranes often
mimicked by dipalmitoylphosphatidylcholine (DPPC). This lipid is chosen to represent the most
abundant head groups in natural membranes [15]. Chimote et al. used Langmuir monolayers to
evaluate the effect of mycolic acid and cord factor (alone and as mixtures) on the surface properties of
DPPC layer [7]. It has been found that both mycobacterial lipids inhibit the surface activity of DPPC;
furthermore, mycolic acid fluidizes the lung surfactant film, and this can contribute to alveolar collapse
in tuberculosis patients.
Various methods have been proposed to inhibit the fission of bacterial cells. Isoniazid (INH)
is a first-line antitubercular agent that inhibits the synthesis of mycolic acids. The interaction
between antituberculosis drugs (such as INH, rifampicin and ethambutol) and DPPC, which is the
main component of the pulmonary surfactant, was investigated by Chimote et al. [16]. Pénzes
et al. [17] studied mycolic-acid-containing lipid monolayer models to interpret the membrane
affinity of antituberculosis drug conjugates. Change induced in the structure of the phospholipid
monolayer by interaction with drug–peptide conjugate was followed by tensiometry and sum-frequency
vibrational spectroscopy [18]. Other antibacterial drug candidates and polymers were also applied to
determine their membrane affinity and in vitro activity, using lipid mono- and bilayer models [19–21].
These studies show the role of the cell envelope in essential processes, and the investigation of its
interactions is still an important research field to develop new drugs or drug–conjugates for more
effective treatments.
Recently, cationic amphiphilic and antimicrobial peptides (AMPs) have received considerable
attention as a possible solution against resistant pathogens. Some of them also showed an anticancer
effect by destabilizing the outer membrane of cancer cells and providing selectivity between normal
and malignant cells [22]. Cell-penetrating peptides (CPP) have a great pharmaceutical potential as
delivery vectors for a wide variety of bioactive cargos. Penetratin [23] and Transportan [24] are among
the most-studied CPPs and have the ability to translocate the plasma membrane, delivering drugs to
the cytoplasm. The antimicrobial peptide Buforin II (5–21) [25] and Magainin II [26] were isolated from
amphibians. Dhvar4 is a synthetic derivative of Histatin, which is a salivary histidine-rich cationic
AMP found in the human parotid secretion [27], Crot(1–9,38–42) [28] and CM15 [29], which are hybrid
AMPs composed of venom peptides. OT20 [30] is a synthetic oligomer of Tuftsin, a receptor-binding
peptide produced by the enzymatic cleavage of the Fc-domain of the heavy chain of immunoglobulin G.
There is a plethora of reports on the investigation of CPPs and AMPs properties [31–33], but most
of them focus on one or two peptides, without comparison of the members of the given family. In our
work, we strived for the comparison of various cationic peptides and their investigation under the
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same measurement conditions with different techniques. This might be useful to reveal the effect of
the composition, polarity, molecular mass and conformational behavior on membrane interactions
and transport. For this purpose, a representative set of cationic membrane active peptides was
selected based on our previous studies on their cell penetrating ability, hemolytic activity, antimicrobial
and cytotoxic effects [34]. Our goal was to identify peptides as promising drug carriers for INH.
The selected peptides and their INH conjugated derivatives were synthetized and used to study
their interactions with DPPC and DPPC + mycolic acid mixed monolayers employing the Langmuir
technique. Circular dichroism spectroscopy (CD) was employed to monitor the secondary structure of
peptides and their INH-conjugates in water and also in membrane mimetic-trifluoroethanol-containing
media. The influence of conjugation was evaluated and compared for the various AMPs. For further
analysis, atomic force microscopy (AFM) was used to image the morphology and structure of
peptide-penetrated lipid layer. Cellular uptake was studied on EBC-1 squamous cell carcinoma as
lung model cells, and the localization of the peptides was imaged by confocal microscopy. Intracellular
killing activity of INH–Penetratin and INH–Transportan was assayed on Mycobacterium tuberculosis
infected human monocytes.
2. Results and Discussion
2.1. Peptide Synthesis and Characterization
Cationic membrane active peptides and their INH-derivatives were synthesized in good yields,
using previously described methods [35]. Peptides were characterized with their monoisotopic
molecular mass (M), retention time on a C-18 RP-HPLC column (Rt), estimated hydrophilicity values
(H) and net charge (z) (see Table 1). Peptides are listed according to their retention times, which are the
indicator of their polarity. OT20 was found to be the most hydrophilic peptide, while Transportan
proved to be the most hydrophobic one in the given set. This order of peptides’ polarity is almost equal
to the relative hydrophilicity estimated from the amino acid composition. The conjugation with INH
does not change the relative polarity of the peptides, as the Rt values show. It is notable, however,
that some increase in the hydrophobicity can be presumed from the slightly increased retention-time
values for most of the peptides (except Buforin and Transportan). That might be the result of decreased
charge due to INH coupling at the N-terminal, although the addition of INH molecule is expected to
increase the polarity of the conjugate.
2.2. Interaction of Peptides and INH–Peptide Conjugates with Lipid Monolayers
The peptide–lipid interactions were investigated by the Langmuir technique, and the results of
the penetration measurements are presented in Figures 1 and 2. The lipid layer was formed from
DPPC and the mixture of DPPC+mycolic acid at ratio of 3:1. The aqueous solution of the peptide or
the INH-conjugated peptide was injected below the compressed (20 mN/m) and conditioned (20 min)
lipid monolayer after 10 min relaxation time. The final concentration was 2 µM in the aqueous phase.
The changes of the surface pressure as a function time was recorded for 1 h. The increase of the surface
pressure (∆Π) gives information of the degree of penetration, which is considered as the membrane
affinity of the given peptide to the lipid layer.
The penetration results showed that the membrane affinity to DPPC layer is modest (∆Π < 2) in
case of OT20, Crot(1–9,38–42) and Buforin II (5–21), but higher for the Penetratin (Figure 1). The other
peptides’ membrane affinity then gradually increased. This shows agreement with our previous
results, where the membrane affinity order of the peptides almost followed their hydrophobicity [37].
Transportan, CM15 and Magainin are shown to be the most hydrophobic ones in the present set,
according to their Rt (>12) and H (< 0) values. Those exhibit significant membrane affinity, exceeding
a 4 mN/m increase in surface pressure. The exact order, however, exposes some differences which
might indicate that other factors than overall hydrophobicity of the peptide also influence the degree
of interaction with the lipid layer.
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Table 1. Analytical characterization of the peptides and INH–peptide conjugates studied in this work.
Compound a Sequence M b Rt c H d Z e
OT20 TKPKGTKPKGTKPKGTKPKG 2062.3 6.7 1.1 9+
Crot(1–9,38–42) YKQCHKKGGKKGSG 1503.8 6.8 0.8 6+
Buforin II (5–21) RAGLQFPVGRVHRLLRK 2001.2 10.9 0.2 6+
Penetratin RQIKIWFQNRRMKWKK 2244.3 10.9 0.5 8+
Dhvar4 KRLFKKLLFSLRKY 1838.2 11.8 0.3 7+
Magainin II GIGKFLHSAKKFGKAFVGEIMNS 2464.3 12.8 −0.1 4+
CM15 KWKLFKKIGAVLKVL 1769.2 13.7 −0.1 6+
Transportan AGYLLGKINLKALAALAKKIL 2180.4 16.8 −0.3 5+
INH–OT20 INH-TKPKGTKPKGTKPKGTKPKG 2239.3 7.0 - 8+
INH–Crot(1–9,38–42) INH-YKQCHKKGGKKGSG 1680.9 7.3 - 5+
INH–Buforin II (5–21) INH-RAGLQFPVGRVHRLLRK 2178.3 11.0 - 5+
INH–Penetratin INH-RQIKIWFQNRRMKWKK 2421.4 11.5 - 7+
INH–Dhvar4 INH-KRLFKKLLFSLRKY 2015.2 12.8 - 6+
INH–Magainin II INH-GIGKFLHSAKKFGKAFVGEIMNS 2641.4 13.3 - 3+
INH–CM15 INH-KWKLFKKIGAVLKVL 1946.2 14.3 - 5+
INH–Transportan INH-AGYLLGKINLKALAALAKKIL 2357.5 16.9 - 4+
a All peptides and conjugates were amidated on the C-terminus and isolated as TFA salts. b Exact mass measured
on a Thermo Scientific Q Exactive™ Focus Hybrid Quadrupole-Orbitrap™ Mass Spectrometer. c Retention time
on a YMC-Pack ODS-A C18 (5 µm, 120 Å) 150 × 4.6 mm column, gradient: 5% B, 2 min; 5%–100% B, 20 min.
d Hydrophilicity was calculated by using values of amino acids expressing hydrophilicity of each amino acid [36].
e Net charge at neutral pH.
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derivatives (orange) into DPPC lipid monolayer after 1 h interaction. (The peptides are presented
according to their increasing Rt values.)
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and DP C+mycolic acid (3:1 mass ratio) (blue) mixed lipi monolayers after 1 h interactio . (The peptide
conjugates are presented according to the r increasing Rt v lues.)
INH conjugation did not change significantly or decrease membrane affinity of peptid s with
DPPC monolayer, except in the case of Buforin II (5–21), Dhvar4 and Transportan, where the penetration
increased. The coupling of INH to the peptides due to the reduction of charge at the N terminal is
expected to increase the hydrophobicity and surface activity character of the conjugate. Therefore,
the penetration of the most hydrophobic peptide, Transportan, is further increased for INH–Transportan.
The explanation might be similar for the case of Dhvar4, where the INH conjugation induced a relative
decrease in polarity counts more because of the lower molecular weight. On the contrary, coupling
INH to highly charged hydrophilic peptides probably does not induce important changes in the polar
character of the derivatives. That is in correspondence with the slightly decreasing membrane affinity
of OT20, Crot(1–9,38–42), Penetratin and CM15 conjugates.
Besides the overall polarity, the conjugation with INH is supposed to induce some structural
changes that lead to preferred or unfavored interaction with lipid layers.
The membrane affinity of the INH-conjugated peptides was also characterized by using another
membrane model, which is formed from DPPC+mycolic acid (3:1) mixture (Figure 2). By mixing
mycolic acid, the monolayer provides a negatively charged layer, which gives the possibility of the
electrostatic interactions with the cationic CPPs. This negatively charged environment in the lipid
membrane favors the insertion of CPPs [31,38]. Moreover, the incorporation of mycolic acid molecules
with long alkyl chains into the lipid layer changes the molecular order and reduces the regular
close packing of the DPPC molecules, allowing the interaction with and penetration of the peptides.
According to the experimental findings, the membrane affinity significantly increased in all cases
except for INH–OT20 and INH–Buforin II (5–21). INH–Transportan and INH–CM15 have the highest
interactions with the DPPC+mycolic acid mixed lipid monolayer.
2.3. Circular Dichroism Spectroscopic Evaluation of the Secondary Structure of CPPs/AMPs and Their
INH Conjugates
Circular dichroism (CD) spectra recorded in the far-UV region (190–260 nm) provides valuable
information on the secondary structure of peptides in a particular medium [39]. In many
instances, cationic AMPs/CPPs are substantially unstructured in aqueous solution but acquire helical
conformation upon contact with negatively charged cell membranes and also in certain organic
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solvents, like trifluoroethanol (TFE) [40–42]. TFE and related haloalcohols provide a low dielectric,
lipomimetic environment which favors and propagates the structuration process of cationic peptides
being disordered in water. Membrane-binding-induced folding of cationic peptides into amphipathic
helices is a crucial step in their biological actions. Therefore, their structural modifications enhancing
helix propensity often result in increased antibacterial and/or hemolytic activity [43–45].
All native peptides studied herein exhibit a main negative CD band in water, with a deep minimum,
around 196–200 nm (Figures 3 and 4). Such a CD pattern is consistent with the dynamic equilibrium of
the mixture of random conformational states. In the presence of TFE, however, a significant amount of
helical structure was induced, as evident from the high-intensity positive–negative CD couplet evolved
below 210 nm and the pronounced minimum at 220–222 nm, which represent the contribution of the
optically active pi-pi* and n-pi* transitions of the peptide bonds arranged along a right-handed helix [39].
Consideration of peak intensities of the CD couplets observed in TFE and water:TFE mixtures permits
comparisons of relative α-helical propensities of the peptides. The largest ∆ε extrema were observed
for CM15, Dhvar4 and Transportan, whereas Penetratin and Magainin II showed somewhat lower
values (Figures 3 and 4). Buforin II (5–21) displayed the weakest helical induction with a ∆εmax of +10
as measured in TFE (Figure 3d).
It is to be noted that Crot(1–9,38–42) and OT20 behaved differently, since neither of them showed
helical conversion upon addition of TFE (Figure 4c,d). For OT20, this result can be explained by the
combined occurrence of proline and glycine residues in the sequence that are well-known, potent
helix breaker residues [46,47]. Crot(1–9,38–42) lacks proline, but its 14 AA long sequence contains
three glycine side chains, creating the highest relative helix breaker frequency among the peptides
under study (apart from OT20). Therefore, glycines might be responsible for preventing the canonical
α-helical folding of Crot(1–9,38–42).
According to our previous data [48–50], small-molecule-binding-induced disorder-to-helix
transitions of cationic AMPs are associated with characteristic CD spectral alterations: In the very first
phase of the titration with the folding inducer, the negative CD band of the peptide below 210 nm
loses intensity, and its λmin is shifted to longer wavelengths. Similar changes were reported for TFE
titration of intrinsically disordered peptides [51] and protein regions [52,53]. Taking these results
into consideration, the bathochromic shift, as well as the intensity reduction of the main CD peak
observed in water, suggests that INH conjugation affects the aqueous conformational equilibrium of
all peptides (Figures 3 and 4). Furthermore, as demonstrated by band-intensity increases for some
peptide conjugates, this effect is more pronounced in TFE and H2O:TFE solution and refers to the
moderate enhancement of the α-helical fraction compared to the native form. Such kinds of spectral
alterations were obtained for INH–Transportan, INH–Magainin II and INH–Buforin II (Figure 3).
The most advanced CD spectral modifications were seen for INH conjugate of Transportan (Figure 3a).
At the short-wavelength side of the aqueous spectrum, the initial part of the helix related positive
CD peak appeared, and the n-pi* CD intensities increased noticeably above 215 nm. Taking into
account the positive correlation between peptide helicity and bilayer-disturbing potency [43–45],
the chiroptical data predict that the INH conjugates bind to lipid membranes with greater affinity
compared to the native peptides. Based on the measure of the conjugation-induced spectroscopic
changes (Figure 3), an estimation of the relative membrane affinity increment can be proposed (in
decreasing order): INH–Transportan, INH–Magainin II, and INH–Buforin II (5–21). Importantly,
this prediction is in good correlation with the membrane affinity enhancement of these conjugates
displayed in Figure 1. However, the reduced ∆ε values of INH–Dhvar4 obtained in TFE and H2O:TFE
mixture indicate a lower helical propensity (Figure 4b), but its DPPC affinity is larger than that of
the parent peptide (Figure 1). In contrast, the reduced CD values above 200 nm in the TFE spectrum
of INH–CM15 (Figure 4a) also suggest a lower helicity that is in line with the decreased membrane
binding shown in Figure 1. Beyond the impact of the helical conformation, these examples warn to the
role of additional INH-conjugation-related physicochemical modifications which may also affect the
peptide-membrane interactions.
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The presence of helix breaker residues makes it difficult to assess the conjugation-induced
structural impact of OT20 and Crot(1–9,38–42) (Figure 4).
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2.4. Atomic Force Microscopy (AFM)
At the end of the membrane affinity measurements, the penetrated monolayers were transferred
to a previously cleaned cover glass, to study the structural changes of the membranes by atomic
force microscopy (Figures 5 and 6). The surface of the original DPPC and mixed DPPC+mycolic acid
monolayer is rather smooth, with a morphology described by typical roughness values presented in
Table 2. (Ra is the average deviation of all points from a mean level over the evaluation area. Rq (RMS)
is the root mean square roughness, while Rz is the average absolute value of the five highest peaks
and the five lowest valleys over the evaluation area, being sensitive to positive or negative extremes
of the image.) Well-defined homogenous lipid islands are formed by the ordered lipid molecules
in equilibrium with the less-oriented film with smaller surface density as expected from the surface
pressure–area isotherm. Comparing to this, the morphology of the penetrated monolayers was changed.
The 3D images provide a visual impression on the surface, while the cross-section profiles allow
the measurement of the height differences. As examples, for INH–Penetratin and INH–Transportan
interaction with DPPC lipid monolayer was found that the homogenous lipid layer was disturbed by
the insertion of the peptide-conjugate and several small aggregates, extended protrusions appeared
with about 1–3 nm height (Figures 5a and 6a). This morphological change can also be expressed by the
roughness factors determined by analyzing the AFM images (Table 2).
Table 2. Roughness values, Ra, Rq and Rz characterizing the morphology of lipid layers and penetrated
lipid layers determined by AFM imaging.
Peptide Lipid System Ra/nm Rq/nm Rz/nm
DPPC 0.10 0.13 0.36
DPPC+mycolic acid 0.25 0.33 1.08
INH–Penetratin
DPPC 0.21 0.27 0.92
DPPC+mycolic acid 0.35 0.45 1.33
INH–Transportan DPPC 0.23 0.37 0.90
DPPC+mycolic acid 0.59 0.94 2.40
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It is noticeable that, considering all three parameters, the roughness of the surface increased
as a result of its interaction with the peptide conjugates. Similar membrane morphology change
was detected previously in the course of interaction of lipid mon layers with cati nic, amphiphilic
polymers presenting antibacterial properties [21].
The result of penetration of INH–Penetratin and INH–Transportan into DPPC+mycolic acid film
was prese ted in Figures 5b and 6b. The disturbance of t e order of lipid molecules and the deviation
from the smooth surface are even higher, in comparison to the correspon i interaction with DPPC
layer. The INH–Transportan forms aggregates as a sort of spherical dots and rings between and wit in
the lipid isla ds with 3–6 m height, while in the case of INH–Penetratin, a generally disturbed surface
appeared with vertical deviati exceeding 3 nm. The intense disturbance of the mixed lipid layer by
interaction with INH–Transportan resulted in the fragmentati n of the monolayer. The appearance of
aggregated structural units is particularly characteristic for the interaction with the negatively charged
DPPC+mycolic acid l yer. It has already been shown that such aggregation is the consequence of the
proximity of the membrane, and this phenomenon can be triggered by a high concentration of the C Ps
on negative phospholipids and induced conform tional changes [32]. The electrostatic interactions
between cationic peptides an egatively charged li id layer facilitate the conformational ch nge,
an agglomeration of CPPs especially for amphipathic peptides such as Penetratin [31].
The significantly enhanc d interacti n of INH–peptide conjugates with the DPPC+mycolic acid
lipid layer, shown by the highly disturbed structure, is in harmony wit their high degr e of penetrati n,
me sured by the increase of surface pressure f the fil (Figure 2). It is also in agreement with the CD
measurements, since this type f morphology might be the result of enhanced membrane interaction,
which involves a membrane-induced increase of the α-helical fraction observed by CD spectroscopy.
2.5. Cellular Uptake, Localization and Efficacy against Intracellular Mycobacterium Tuberculosis
For the in vitro biological evaluation, two peptides were selected, namely Penetratin and
Transportan, which are the two most-studied cell-penetrating peptides. Internalization of the peptides
was measured on EBC-1 human squamous cell carcinoma, which was chosen as a lung cell model.
Squamous-cell aggregates are common within the lung tissue associated with Mycobacterium tuberculosis
(Mtb) infection. Mtb infected host cells (mainly macrophages and other lung tissue cells) play a
pivotal role in chronic-tuberculosis-induced carcinogenesis caused by DNA damage, growth factors,
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proliferative activities, etc. To eliminate the intracellular bacteria from the host cells is crucial for
successful therapy. The infection caused mainly by proliferative changes in the lung tissue (mainly
in bronchial and alveolar mucosa) that Mtb leaves behind cannot be ignored [54,55]. Therefore,
squamous cell culture can be employed as a suitable model to investigate the main features of the
carrier peptides. Flow cytometric measurements revealed a concentration-dependent internalization
of the peptides. Penetratin and Transportan showed similar internalization potency based on the
detected fluorescent intensity measured by flow cytometry (Figure 7a). However, on the confocal
microscopy images, markedly different subcellular localization was observed. Penetratin showed
diffused intracellular distribution, while in the case of Transportan, mostly vesicular localization
was captured (Figure 7b). Besides cytoplasmic localization, Penetratin showed co-localization with
lysosomal and nucleus staining, possibly indicating that this compound internalizes not only through
the endo-lysosomal pathway, but also through direct cell penetration (Figure 7b). This observation is
in line with previous reports on the nuclear translocation of Penetratin [56]. The vast majority of CPPs
can be trapped in endosomes, following delivery into the cells. Subsequently, any conjugated cargo
might be trapped, as well [57]. Significantly lower intracellular antitubercular activity of Transportan
(Figure 7c) might be the consequence of an endosomal escape problem, while the diffuse intracellular
delivery makes INH–Penetratin an efficient candidate against intracellular Mycobacterium tuberculosis
(Figure 7d).
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Figure 7. Internalization and intracellular antibacterial activity of the peptides. Cellular uptake of
EBC-1 human lung carcinoma cells was measured by flow cytometry after 2 h treatment with 5 and
10 µM peptide concentration (a). Localization of 5(6)-ca boxyfluorescein-labeled Penet atin and
Transportan in EBC-1 cells was visualized by c nfocal laser scanning microscopy (b). Cells were
incubated with Cf -labeled peptides (green), lysosomes were stained with LysoTracker Deep Red (red)
and nuclei were stained with Hoechst 33342 (blue). The scale bar represents 20 µm. Penetratin and
Transportan were conjugated with Isoniazid, and INH–Penetratin and INH–Transportan were assayed
against Mycobacterium tuberculosis-infected MonoMac-6 human monocytes. After treatment, cells were
lysed with SDS, and number of bacteria was enumerated on LJ tubes (c,d).
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3. Materials and Methods
3.1. Peptide Synthesis and Characterization
For peptide synthesis, amino acid derivatives were obtained from Iris Biotech (Germany).
The reagents N,N’-diisopropylcarbodiimide (DIC), triisopropylsilane (TIS), 1-hydroxybenzotriazole
(HOBt), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), isoniazid (INH), glyoxylic acid and 5(6)-carboxy
fluorescein (Cf ) were purchased from Sigma-Aldrich (Budapest, Hungary). Fmoc-Rink Amide MBHA
resin was from Merck (Budapest, Hungary). Trifluoroacetic acid (TFA),N,N-dimethylformamide (DMF),
dichloromethane (DCM), diethyl ether and acetonitrile (AcN) were from VWR (Budapest, Hungary).
For the in vitro assays, RPMI-1640 medium, fetal calf serum (FCS) and trypan blue were obtained
from Sigma-Aldrich. Trypsin was from Gibco. HPMI buffer (9 mM glucose, 10 mM NaHCO3, 119 mM
NaCl, 9 mM HEPES, 5 mM KCl, 0.85 mM MgCl2, 0.053 mM CaCl2, 5 mM Na2HPO4×2H2O, pH = 7.4)
was prepared in-house, using components obtained from Sigma-Aldrich (Budapest, Hungary).
Synthetic Procedures
Peptides were produced on solid phase (Fmoc-Rink Amide MBHA resin, capacity = 0.67 mmol/g),
in an automated peptide synthesizer (Syro-I, Biotage, Uppsala, Sweden), using standard Fmoc/tBu
strategy with DIC/HOBt coupling reagents. Isoniazid was conjugated to the N-terminus of the
peptides by using glyoxylic acid as a linker (the synthesis is detailed in [35]). Fluorescently labeled
derivatives were synthesized with the use of 5(6)-carboxyfluorescein (Cf ) with DIC/HOBt coupling
method. Peptides were cleaved from the resin with TFA/H2O/TIS (9.5:2.5:2.5 v/v) mixture (2 h, RT).
After filtration, compounds were precipitated in cold diethyl ether, centrifuged (4000 rpm, 5 min) and
freeze-dried from water.
RP-HPLC purification was performed on a Thermo Fisher UltiMate 3000 Semiprep HPLC with a
Phenomenex Jupiter Proteo C-12 column (250 × 10 mm), using gradient elution, consisting of 0.1%
TFA in water (eluent A) and 0.1% TFA in acetonitrile/water = 80/20 (v/v) (eluent B).
Purified peptides were analyzed by RP-HPLC, on an analytical C-18 column, using gradient
elution with the abovementioned eluent A and B (flow rate was 1 mL/min, UV detection at λ = 220 nm).
Molecular mass of the peptides was determined on a Thermo Scientific Q Exactive™ Focus Hybrid
Quadrupole-Orbitrap™ Mass Spectrometer (ThermoFisher Scientific, Waltham, MA, USA).
3.2. Membrane Affinity Measurements
Monomolecular lipid membrane models were used to characterize the interactions between
the monolayers and a series of isoniazid (INH)-conjugated peptides. The membrane affinity was
investigated by using the Langmuir technique. Surface pressure was recorded with the tensiometric
method, with ±0.5 mN/m accuracy, employing previously purified filter papers, such as Wilhelmy
plates. The trough was made of Teflon and was equipped with one surface pressure sensor and
two polyoxymethylene (POM) barriers. Dichloromethane (VWR Chemicals, analytical purity) and
methanol (VWR Chemicals, Reag. Ph. Eur. for HPLC) were used for the cleaning of the troughs and
barriers before each measurement. Then, 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) (Avanti
Polar Lipids Inc., Alabaster, AL, USA) and its mixture with mycolic acid from Mycobacterium tuberculosis
(human strain) (98% Sigma-Aldrich) were applied in chloroform (VWR Chemicals, analytical purity),
to form the monomolecular lipid layer on the top of the double-distilled water subphase in the
Langmuir through. (Molecular structure of isoniazid, DPPC and mycolic acid are presented in Figure 8).
The composition of the lipid mixture was a mass ratio of 75w% DPPC and 25w% mycolic acid.
Double-distilled water was checked by its conductivity (<5 mS) and surface tension (>72.0 mN/m
at 23± 0.5 ◦C) values. After the cleaning procedure, the through was filled with double-distilled
water. DPPC or the mixture of DPPC and mycolic acid was dissolved in chloroform to a concentration
0.2 mg/mL. The lipid solution was spread on the subphase. The system was left for 10 min, to evaporate
the chloroform, before the compression. Surface pressure–area isotherms were recorded two times
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before each penetration measurement. The lipid layer was conditioned by barrier adjustment for
20 min, and the aqueous solution of the peptide was injected under the lipid monolayer, after 10 min
relaxation time. The peptides were dissolved in double-distilled water, at 200 µM concentration.
This peptide solution was injected into the subphase, to achieve 2 µM final concentration. The changes
of the surface pressure as a function of time were recorded for 1 h.
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CD curves were taken on a JASCO J-715 spectropolarimeter, at 25 ± 0.2 ◦C, in 0.5 cm path-length
rectangular quartz cuvette (Hellma, Plainview, NY, USA). Temperature control was provided by a
Peltier thermostat. The CD data were monitored in continuous sca ning mode, betwee 190 and
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3.4. Atomic Force Microscopy Measurements
Penetrated Langmuir monolayers were transferred to a previously cleaned hydrophilic cover
glass for atomic microscopy measurements. The cover glasses were cleaned by ultra-cleaning, with
the mixture of H2O2 and H2SO4, for two hours. After washing and drying, they were suitable for
the deposition. The structure of the monolayers was investigated by Nanosurf Flex-Axiom (Liestal,
Switzerland) atomic force microscope system, operating in contact mode. Silicon cantilever ContGD-G
(BudgetSensors) was used, with a tip curvature radius less than 10 nm, an average force constant of
0.2 N/m, resonance frequency of 13 kHz and with gold reflective coating. Each sample was imaged in
2 × 2 µm2 areas, at 10 randomly selected locations. The image analysis was performed by Gwyddion
2.50 program.
3.5. In Vitro Assays
3.5.1. Cellular Uptake and Localization of the Peptides
Internalization of Cf -labeled Penetratin and Transportan was measured on EBC-1 (squamous cell
carcinoma, origin: bronchi) [58,59]. Cells were maintained as an adherent culture in DMEM medium
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supplemented with 10% heat-inactivated fetal calf serum (FCS) l-glutamine (2 mM) and gentamicin
(35 µM), at 37 ◦C, in a humidified atmosphere containing 5% CO2. For the assay, cells were treated with
peptides at 5 and 10 µM final concentration and were incubated for 2 h. After centrifugation (1000 rpm,
5 min) and washing with serum-free DMEM medium, supernatant was removed, and 100 µL 0.25%
trypsin was added to the cells. After 10 min incubation, 0.8 mL 10% FCS/HPMI medium was added,
and then cells were washed and resuspended in 0.25 mL HPMI medium. The intracellular fluorescence
intensity of the cells was measured on a BD LSR II flow cytometer (BD Biosciences, San Jose, CA,
USA) on channel FITC (emission at λ = 505 nm), and data were analyzed with FACSDiva 5.0 software.
All measurements were performed in triplicates, and the mean fluorescent intensity, together with
standard error of the mean (SEM), was graphically presented.
Localization of the peptides was visualized by confocal microscopy. EBC-1 cells were seeded (105
cells/well) one day prior to treatment, on cover glass containing 24-well plates (Sarstedt, Nümbrecht,
Germany). Lysosomes were stained by LysoTracker™ Deep Red (Invitrogen, Carlsbad, CA, USA) for
30 min, followed by incubation with Cf -labeled Penetratin and Transportan for 60 min. Subsequently,
nuclei were stained by Hoechst 33342 solution (Thermo Scientific, Waltham, MA, USA). After each step,
cells were washed three times with serum-free medium. Cells were fixed by 4% paraformaldehyde for
15 min and mounted to microscopy slides with Mowiol® 4–88. Imaging was performed on a Zeiss
LSM 710 system with 40× oil immersion objective. Images were processed with ZEN lite software
(Zeiss, Oberkochen, Germany).
3.5.2. Determination of Antibacterial Efficacy against Intracellular Mycobacterium tuberculosis
MonoMac-6 human monocytes (2 × 105 cells/1 mL medium/well) were cultured in RPMI-1640
medium containing 10 % FCS, in a 24-well plate, 24 h prior to the experiment. Adherent cells
were infected with Mycobacterium tuberculosis H37Rv, at a multiplicity of infection (MOI) of 10.
Nonphagocytosed extracellular bacteria were removed by washing the culture three times with
serum-free RPMI. After 1 day of incubation, infected cells were treated with INH-conjugated Penetratin
and Transportan 5, 10 and 50 µM final concentrations. For comparison, INH was also assayed at 100 µM
concentration. As control, infected cells were treated with culture media. After 3 days, the treatment
was repeated with fresh solutions of the compounds, and cells were incubated for an additional 3
days. After 3 washing steps, infected cells were lysed with 2.5 % sodium dodecyl sulphate (SDS)
solution, and 100 µL lysate was transferred to L-J medium (BBL Löwenstein–Jensen medium, Beckton
Dickinson). Colony-forming units (CFU) were enumerated after 4 weeks of incubation, and the number
of bacteria was calculated by using a standard dilution series of M. tuberculosis [60].
4. Conclusions
INH-conjugated peptides with various composition, hydrophobicity and charge character were
compared in an experimental membrane affinity study, using lipid monolayer models. In most cases,
increased membrane affinity was observed, especially with mycolic-acid-containing lipid layer induced
by the conjugation with INH. Hydrophobic character of the peptides seems to favor the interaction
with lipid layers within the set of cationic peptides studied here. CD spectroscopic measurement
allowed for the analysis of the correlation between the secondary structural change of the peptides and
their INH-conjugates and the membrane affinity. The penetration into the lipid layer was in line with
the destruction of ordered structure of lipid layer observed visually by AFM in nanometric range.
In vitro assays supported the cellular uptake and antibacterial effect of the INH–peptide conjugates;
furthermore, an important difference in the intracellular localization was also revealed, depending
on the carrier peptide. Nuclear translocation of Penetratin and its ability to carry various chemically
conjugated cargos within the nucleus has been reported so far [56], and this feature made Penetratin a
good candidate to utilize in gene therapy [61,62]. Our recent study added a supplement feature to
Penetratin as a carrier molecule, namely the use as vector for peptide delivery of antitubercular agents
and utilization of it against intracellular bacteria.
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